doi: 10.1016/j.jse.2019.12.002 Summary Keywords gastric distension, intestinal distension, glucagon-like peptide-1, vagal afferents, food intake, insulin sensitivity, obesity, feeding rhythm Citation Ohbayashi K, Oyama Y, Yamaguchi C, Asano T, Yada T and Iwasaki Y (2021) Gastrointestinal Distension by Pectin-Containing Carbonated Solution Suppresses Food Intake and Enhances Glucose Tolerance via GLP-1 Secretion and Vagal Afferent Activation
It argues that the drug class is hybrid
Patients need ongoing guidance, clear progress tracking, structured coaching touchpoints, and easy access to their care plan
Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits
How much does PlexusDx compounded semaglutide cost, and do storage requirements affect pricing
These findings uncover a non-canonical mechanism of action for GLP-1 analogs, highlighting a specific microbiota-endocannabinoid metabolic pathway as a potential therapeutic target for depression.